Inhibition of pyruvate dehydrogenase kinase‑1 by dicoumarol enhances the sensitivity of hepatocellular carcinoma cells to oxaliplatin via metabolic reprogramming-Reference-Cited by-同舟云学术

Inhibition of pyruvate dehydrogenase kinase‑1 by dicoumarol enhances the sensitivity of hepatocellular carcinoma cells to oxaliplatin via metabolic reprogramming

Published:2020-07-10 Issue:3 Volume:57 Page:733-742
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Xu Huadan¹,He Yichun²,Ma Jiaoyan¹,Zhao Yuanxin¹,Liu Yanan¹,Sun Liankun¹,Su Jing¹

Affiliation:

1. Key Laboratory of Pathobiology, Ministry of Education, Department of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin 130021, P.R. China

2. Department of Neurosurgery, China‑Japan Union Hospital, Jilin University, Changchun, Jilin 130021, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer;International Journal of Molecular Sciences;2024-01-09

2. Licoricidin Hinders Proliferation and Induces Cell Cycle Arrest and Apoptosis in Hepatocellular Carcinoma Cells by Regulating the PDK1/AKT/P21 Pathway;J BIOL REG HOMEOS AG;2024

3. Glucose metabolism disorder: a potential accomplice of SARS-CoV-2;International Journal of Obesity;2023-08-04

4. Unraveling the Sweet Secrets of HCC: Glucometabolic Rewiring in Hepatocellular Carcinoma;Technology in Cancer Research & Treatment;2023-01

5. Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects;Technology in Cancer Research & Treatment;2023-01